Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: A Closer Look At Boehringer Ingelheim’s Partnering Strategy

Sep 20 2024

• By Joseph Haas, Vibha Ravi, and Lisa Takagi

Deal Watch 2021 — • Source: Shutterstock

Related Content

Boehringer Looks To Revitalise Its Pipeline

Jul 18 2024

Lilly And EVA Pharma Sign Voluntary License Deal For Baricitinib In Africa

Sep 06 2024

Aspen Looks To Soar In GLP-1s With Commercial, Manufacturing Arrangement

Sep 05 2024

Fresenius Offloads Chilean Operation As It Slims Down Manufacturing

Sep 03 2024

136 Years And Counting: Boehringer Ingelheim Sees Advantage In Private Structure

Jul 21 2021

Novartis Bets Big On Next-Gen Gene Therapy With Voyager Pact

Mar 08 2022

Advanz Adds Biosimilars Alliance With Alkem’s Enzene

Aug 28 2024

Tech Transfer Roundup: Tiba And CEPI Strategize Together On ‘Disease X’

Jan 18 2023

Former Hilleman CEO On Microbiome Project, Cholera, Halal Vaccine

Sep 09 2024

Boehringer Backs Up Best-In-Class MASH Claims With Fibrosis Data

Jun 07 2024

Best Practices For Offering Value To Potential Partners – Highlights From LSX

Sep 13 2024

Stock Watch: Bad Deals Backfire On Bayer And CSL

Aug 26 2024

Five Recent Deals Show ADCs Aren’t Cooling Off For Summer

Aug 23 2024

Borealis Seeks Aurora In RNA-Based Drugs For Renal Disease

Aug 22 2024

Navigator Medicines Emerges With $100m, Autoimmune Candidate

Aug 27 2024

Old Flame Indivior Aids Addex After Being Jilted By J&J

Aug 28 2024

Pfizer And Flagship’s Quotient To Seek Out New Heart And Kidney Drugs

Aug 28 2024

Honey, I Shrunk The Drugs: Novartis, Lindy Partner On Biologics Delivery

Aug 28 2024

Bayer Returns To Cancer Drug In-Licensing With NextRNA Deal

Aug 29 2024

Ipsen Outpaces Market With Lucrative Priority Review Voucher Deal

Aug 30 2024

HAYA To Complement Lilly’s Metabolic Disease Efforts With Long Non-Coding RNA

Sep 05 2024

J&J Interested In ‘Differentiated’ Obesity Assets

Sep 04 2024

Roivant’s Pulmovant Emerges After Stealth Development Plan

Sep 10 2024

Hikma Bolsters Injectables With Completion Of Xellia Deal

Sep 11 2024

Sanofi And ITM Make Radio Waves

Sep 12 2024

Organon Moves Into Branded Dermatology With Dermavant Takeout

Sep 18 2024

Tobacco Giant Philip Morris To Offload Vectura After Controversy Scuppered Relationships

Sep 19 2024

Zydus Signs MRI Contrast Agent Licensing Deal With A Market Worth Of $237m

Sep 19 2024

Newron Weighs Up Partners Or M&A As Excitement Grows Over Antipsychotic

Sep 19 2024

Chinese Firms To Dominate Domestic Cell Therapy Market As Gilead Exits

Sep 20 2024

Related Companies

Proveca Ltd.

Cessatech A/S

Novartis AG

Voyager Therapeutics, Inc

ERS Genomics Limited

Medicines Discovery Catapult

CancerVax

Boehringer Ingelheim GmbH

Eli Lilly and Company

Ripple Therapeutics Corporation

Korro Bio, Inc.

Novo Nordisk A/S

Bharat Biotech

Alopexx, Inc.

Hilleman Laboratories Pvt. Ltd.

Contraline, Inc.

Harvard University

Unravel Biosciences, Inc.

Jackson Laboratory

Moffitt Cancer Center

Additional Topics

Business Strategies Deals Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window